Aier Eye Hospital Group Co., Ltd.

Shenzhen Stock Exchange 300015.SZ

Aier Eye Hospital Group Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 5.56

Aier Eye Hospital Group Co., Ltd. Price to Sales Ratio (P/S) is 5.56 on January 14, 2025, a -15.57% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Aier Eye Hospital Group Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 8.79 on October 08, 2024, which is 57.97% above the current Price to Sales Ratio (P/S).
Aier Eye Hospital Group Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 4.17 on August 27, 2024, which is -25.14% below the current Price to Sales Ratio (P/S).
Aier Eye Hospital Group Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 5.72.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shenzhen Stock Exchange: 300015.SZ

Aier Eye Hospital Group Co., Ltd.

CEO	Mr. Bang Chen
IPO Date	Oct. 30, 2009
Location	China
Headquarters	New Century Mansion No. 198
Employees	36,718
Sector	Health Care
Industries Hospitals & Clinics Eyewear

Description

Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.

Key trends

Past 5 years